These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 15629361

  • 21. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Novel Chlamydia pneumoniae vaccine candidates confirmed by Th1-enhanced genetic immunization.
    Li Y, Ahluwalia SK, Borovkov A, Loskutov A, Wang C, Gao D, Poudel A, Sykes KF, Kaltenboeck B.
    Vaccine; 2010 Feb 10; 28(6):1598-605. PubMed ID: 19961962
    [Abstract] [Full Text] [Related]

  • 25. [Signs of active infection with Chlamydia pneumoniae in patients with coronary heart disease].
    Hrubá D, Roubalová K, Kraml P, Andĕl M.
    Cas Lek Cesk; 2004 Feb 10; 143(12):830-5. PubMed ID: 15730214
    [Abstract] [Full Text] [Related]

  • 26. Rational antibacterial vaccine design through genomic technologies.
    Grandi G.
    Int J Parasitol; 2003 May 10; 33(5-6):615-20. PubMed ID: 12782059
    [Abstract] [Full Text] [Related]

  • 27. Expression library immunization confers partial protection against Chlamydia muridarum genital infection.
    McNeilly CL, Beagley KW, Moore RJ, Haring V, Timms P, Hafner LM.
    Vaccine; 2007 Mar 30; 25(14):2643-55. PubMed ID: 17239501
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Chlamydia pneumoniae infections augment atherosclerotic lesion formation: a role for serum amyloid P.
    Ezzahiri R, Stassen FR, Kurvers HR, Dolmans V, Kitslaar PJ, Bruggeman CA.
    APMIS; 2006 Feb 30; 114(2):117-26. PubMed ID: 16519748
    [Abstract] [Full Text] [Related]

  • 31. Collaborative multidisciplinary workshop report: progress toward a Chlamydia pneumoniae vaccine.
    Murdin AD, Gellin B, Brunham RC, Campbell LA, Christiansen G, Deal CD, Jenson HB, Metcalf B, Sankaran B, Stephens RS, Wilfert C.
    J Infect Dis; 2000 Jun 30; 181 Suppl 3():S552-7. PubMed ID: 10839757
    [No Abstract] [Full Text] [Related]

  • 32. Role of polymorphonuclear neutrophils (PMNs) and NK cells in the protection conferred by different vaccines against Chlamydophila abortus infection.
    Ortega N, Caro MR, Buendía AJ, Gallego MC, Del Río L, Martínez CM, Nicolas L, Cuello F, Salinas J.
    Res Vet Sci; 2007 Jun 30; 82(3):314-22. PubMed ID: 17046037
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Diagnostic value of an ELISA using a recombinant 54-kDa species-specific protein from Chlamydia pneumoniae.
    Sueur JM, Beaumont K, Cabioch T, Orfila J, Betsou F.
    Clin Microbiol Infect; 2006 May 30; 12(5):470-7. PubMed ID: 16643525
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Systemic and mucosal antibody response in experimental Chlamydia pneumoniae infection of mice.
    Penttilä T, Wahlström E, Vuola JM, Sarvas M, Puolakkainen M.
    Comp Med; 2006 Aug 30; 56(4):272-8. PubMed ID: 16941954
    [Abstract] [Full Text] [Related]

  • 37. Clearance of Chlamydia pneumoniae infection in H-2 class I human leucocyte antigen-A2.1 monochain transgenic mice.
    Tammiruusu A, Haveri A, Pascolo S, Lahesmaa R, Stevanovic S, Rammensee HG, Sarvas M, Puolakkainen M, Vuola JM.
    Scand J Immunol; 2005 Aug 30; 62(2):131-9. PubMed ID: 16101819
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.